US Stock MarketDetailed Quotes

FHTX Foghorn Therapeutics

Watchlist
  • 7.840
  • +0.120+1.55%
Close Nov 22 16:00 ET
  • 7.840
  • 0.0000.00%
Post 16:02 ET
435.85MMarket Cap-4237P/E (TTM)

Foghorn Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Foghorn Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 5.977M--
--2024/Q4-- / 8.136M--
--2024/Q37.808M / 7.010M--
--2024/Q26.888M / 6.726M--
--2024/Q15.050M / 7.352M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 5.977M--
--2024/Q4-- / 8.136M--
--2024/Q37.808M / 7.010M--
--2024/Q26.888M / 6.726M--
--2024/Q15.050M / 7.352M--

Unlock Free Earnings Estimates

Foghorn Therapeutics Earnings Reports

  • Foghorn Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 4 16:22 ET

  • Foghorn Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 8 07:09 ET

  • Foghorn Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 6 07:08 ET

  • Foghorn Therapeutics | 10-K: FY2023 Annual Report

    Mar 7 07:14 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 24, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data